annual accounts payable:
$405.00M-$115.00M(-22.12%)Summary
- As of today (May 19, 2025), MRNA annual accounts payable is $405.00 million, with the most recent change of -$115.00 million (-22.12%) on December 31, 2024.
- During the last 3 years, MRNA annual accounts payable has risen by +$103.00 million (+34.11%).
- MRNA annual accounts payable is now -22.12% below its all-time high of $520.00 million, reached on December 31, 2023.
Performance
MRNA Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$226.00M-$179.00M(-44.20%)Summary
- As of today (May 19, 2025), MRNA quarterly accounts payable is $226.00 million, with the most recent change of -$179.00 million (-44.20%) on March 31, 2025.
- Over the past year, MRNA quarterly accounts payable has increased by +$43.00 million (+23.50%).
- MRNA quarterly accounts payable is now -56.54% below its all-time high of $520.00 million, reached on December 31, 2023.
Performance
MRNA quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MRNA Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.1% | +23.5% |
| 3 y3 years | +34.1% | +13.6% |
| 5 y5 years | +5612.3% | +1948.2% |
MRNA Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.1% | +34.1% | -56.5% | +24.9% |
| 5 y | 5-year | -22.1% | +5612.3% | -56.5% | +2725.0% |
| alltime | all time | -22.1% | >+9999.0% | -56.5% | >+9999.0% |
MRNA Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $226.00M(-44.2%) |
| Dec 2024 | $405.00M(-22.1%) | $405.00M(+8.6%) |
| Sep 2024 | - | $373.00M(+33.7%) |
| Jun 2024 | - | $279.00M(+52.5%) |
| Mar 2024 | - | $183.00M(-64.8%) |
| Dec 2023 | $520.00M(+6.8%) | $520.00M(+5.3%) |
| Sep 2023 | - | $494.00M(+59.4%) |
| Jun 2023 | - | $310.00M(-20.3%) |
| Mar 2023 | - | $389.00M(-20.1%) |
| Dec 2022 | $487.00M(+61.3%) | $487.00M(+47.6%) |
| Sep 2022 | - | $330.00M(+82.3%) |
| Jun 2022 | - | $181.00M(-9.0%) |
| Mar 2022 | - | $199.00M(-34.1%) |
| Dec 2021 | $302.00M(+1577.8%) | $302.00M(+247.1%) |
| Sep 2021 | - | $87.00M(+13.0%) |
| Jun 2021 | - | $77.00M(+862.5%) |
| Mar 2021 | - | $8.00M(-55.6%) |
| Dec 2020 | $18.00M(+153.9%) | $18.00M(-12.3%) |
| Sep 2020 | - | $20.52M(+9.1%) |
| Jun 2020 | - | $18.82M(+70.5%) |
| Mar 2020 | - | $11.03M(+55.6%) |
| Dec 2019 | $7.09M(-77.3%) | $7.09M(-39.6%) |
| Sep 2019 | - | $11.74M(-60.4%) |
| Jun 2019 | - | $29.61M(-23.1%) |
| Mar 2019 | - | $38.51M(+23.4%) |
| Dec 2018 | $31.21M(+50.6%) | $31.21M(+28.1%) |
| Sep 2018 | - | $24.36M(+17.5%) |
| Dec 2017 | $20.73M(-26.4%) | $20.73M(+1917.0%) |
| Sep 2017 | - | $1.03M(+9.5%) |
| Jun 2017 | - | $938.40K(+51.6%) |
| Mar 2017 | - | $618.80K(-6.7%) |
| Dec 2016 | $28.16M(+3590.3%) | - |
| Dec 2016 | - | $663.30K(-55.8%) |
| Sep 2016 | - | $1.50M(+12.6%) |
| Jun 2016 | - | $1.33M(+29.2%) |
| Mar 2016 | - | $1.03M(+35.1%) |
| Dec 2015 | $763.00K(+11.1%) | $763.00K(+0.5%) |
| Sep 2015 | - | $759.00K(+51.2%) |
| Jun 2015 | - | $502.00K(-13.6%) |
| Mar 2015 | - | $581.00K(-15.4%) |
| Dec 2014 | $687.00K(-57.4%) | $687.00K(-44.5%) |
| Sep 2014 | - | $1.24M(+17.6%) |
| Jun 2014 | - | $1.05M(-33.8%) |
| Mar 2014 | - | $1.59M(-1.5%) |
| Dec 2013 | $1.61M(+0.5%) | $1.61M(+7.3%) |
| Sep 2013 | - | $1.50M(-4.8%) |
| Jun 2013 | - | $1.58M(-5.6%) |
| Mar 2013 | - | $1.67M(+4.2%) |
| Dec 2012 | $1.61M(-36.7%) | $1.61M(-8.8%) |
| Sep 2012 | - | $1.76M(-50.3%) |
| Jun 2012 | - | $3.54M(+8.8%) |
| Mar 2012 | - | $3.26M(+28.4%) |
| Dec 2011 | $2.54M(-35.3%) | $2.54M(+15.4%) |
| Sep 2011 | - | $2.20M(-15.9%) |
| Jun 2011 | - | $2.61M(-21.2%) |
| Mar 2011 | - | $3.31M(-15.5%) |
| Dec 2010 | $3.92M(+85.5%) | $3.92M(+85.5%) |
| Sep 2010 | - | $2.11M(-21.1%) |
| Jun 2010 | - | $2.68M(+25.2%) |
| Mar 2010 | - | $2.14M(+1.2%) |
| Dec 2009 | $2.11M | $2.11M(+85.3%) |
| Sep 2009 | - | $1.14M(-7.9%) |
| Jun 2009 | - | $1.24M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $1.15M(-43.6%) |
| Dec 2008 | $2.04M(-51.6%) | $2.04M(+55.5%) |
| Sep 2008 | - | $1.31M(-43.5%) |
| Jun 2008 | - | $2.32M(-17.0%) |
| Mar 2008 | - | $2.79M(-33.7%) |
| Dec 2007 | $4.22M(-5.0%) | $4.22M(+24.8%) |
| Sep 2007 | - | $3.38M(+32.9%) |
| Jun 2007 | - | $2.54M(-34.9%) |
| Mar 2007 | - | $3.91M(-11.9%) |
| Dec 2006 | $4.44M(+50.7%) | $4.44M(+29.2%) |
| Sep 2006 | - | $3.43M(-1.6%) |
| Jun 2006 | - | $3.49M(+66.3%) |
| Mar 2006 | - | $2.10M(-28.8%) |
| Dec 2005 | $2.94M(+78.2%) | $2.94M(+2.0%) |
| Sep 2005 | - | $2.88M(-11.2%) |
| Jun 2005 | - | $3.25M(+18.8%) |
| Mar 2005 | - | $2.73M(+65.6%) |
| Dec 2004 | $1.65M(-30.9%) | $1.65M(-9.1%) |
| Sep 2004 | - | $1.82M(-2.7%) |
| Jun 2004 | - | $1.87M(+1.0%) |
| Mar 2004 | - | $1.85M(-22.6%) |
| Dec 2003 | $2.39M(+88.3%) | $2.39M(+34.7%) |
| Sep 2003 | - | $1.77M(-7.7%) |
| Jun 2003 | - | $1.92M(+101.3%) |
| Mar 2003 | - | $955.00K(-24.7%) |
| Dec 2002 | $1.27M(+127.0%) | $1.27M(-23.8%) |
| Sep 2002 | - | $1.67M(+31.6%) |
| Jun 2002 | - | $1.26M(+37.8%) |
| Mar 2002 | - | $918.00K(+64.2%) |
| Dec 2001 | $559.00K(-13.7%) | $559.00K(-19.5%) |
| Sep 2001 | - | $694.00K(-4.9%) |
| Jun 2001 | - | $730.00K(+35.7%) |
| Mar 2001 | - | $538.00K(-17.0%) |
| Dec 2000 | $648.00K(-69.1%) | $648.00K(-37.6%) |
| Sep 2000 | - | $1.04M(-1.9%) |
| Jun 2000 | - | $1.06M(+39.4%) |
| Mar 2000 | - | $759.00K(-63.9%) |
| Dec 1999 | $2.10M(+250.0%) | $2.10M(+31.3%) |
| Sep 1999 | - | $1.60M(+100.0%) |
| Jun 1999 | - | $800.00K(-38.5%) |
| Mar 1999 | - | $1.30M(+116.7%) |
| Dec 1998 | $600.00K(-60.0%) | $600.00K(-50.0%) |
| Sep 1998 | - | $1.20M(-7.7%) |
| Jun 1998 | - | $1.30M(+62.5%) |
| Mar 1998 | - | $800.00K(-46.7%) |
| Dec 1997 | $1.50M(+150.0%) | $1.50M(+66.7%) |
| Sep 1997 | - | $900.00K(+12.5%) |
| Jun 1997 | - | $800.00K(+14.3%) |
| Mar 1997 | - | $700.00K(+133.3%) |
| Dec 1996 | $600.00K(+20.0%) | - |
| Sep 1996 | - | $300.00K(-40.0%) |
| Jun 1996 | $500.00K(0.0%) | $500.00K(0.0%) |
| Mar 1996 | - | $500.00K(0.0%) |
| Dec 1995 | - | $500.00K(-28.6%) |
| Sep 1995 | - | $700.00K(+40.0%) |
| Jun 1995 | $500.00K(0.0%) | $500.00K(+25.0%) |
| Mar 1995 | - | $400.00K(-20.0%) |
| Dec 1994 | - | $500.00K(0.0%) |
| Sep 1994 | - | $500.00K(0.0%) |
| Jun 1994 | $500.00K | $500.00K(0.0%) |
| Mar 1994 | - | $500.00K(-16.7%) |
| Dec 1993 | - | $600.00K(+20.0%) |
| Sep 1993 | - | $500.00K |
FAQ
- What is Moderna annual accounts payable?
- What is the all time high annual accounts payable for Moderna?
- What is Moderna annual accounts payable year-on-year change?
- What is Moderna quarterly accounts payable?
- What is the all time high quarterly accounts payable for Moderna?
- What is Moderna quarterly accounts payable year-on-year change?
What is Moderna annual accounts payable?
The current annual accounts payable of MRNA is $405.00M
What is the all time high annual accounts payable for Moderna?
Moderna all-time high annual accounts payable is $520.00M
What is Moderna annual accounts payable year-on-year change?
Over the past year, MRNA annual accounts payable has changed by -$115.00M (-22.12%)
What is Moderna quarterly accounts payable?
The current quarterly accounts payable of MRNA is $226.00M
What is the all time high quarterly accounts payable for Moderna?
Moderna all-time high quarterly accounts payable is $520.00M
What is Moderna quarterly accounts payable year-on-year change?
Over the past year, MRNA quarterly accounts payable has changed by +$43.00M (+23.50%)